IPD.AX - ImpediMed Limited
ImpediMed Limited
50 Parker Court
Unit 1
Pinkenba, QLD 4008
Australia
61 7 3860 3700
https://www.impedimed.com
Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 73
Key executives
| Name | Title | Pay | Exercised | Year born |
|---|---|---|---|---|
| Mr. Timothy Cruickshank | Chief Financial Officer | 486.89k | N/A | N/A |
| Mr. Shashi Tripathi | COO & Chief Customer Officer | 507.24k | N/A | N/A |
| Mr. Dennis Schlaht | Sr. VP of R&D and Technology | 478.63k | N/A | N/A |
| Mr. David W. Anderson B.S., B.Sc. | Exec. Director | 39.58k | N/A | 1954 |
| Mr. Richard P. Valencia | MD, CEO & Director | N/A | N/A | 1963 |
| Ms. Joann Yao | VP of Marketing | N/A | N/A | N/A |
| Dr. Thomas Schenk | Chief Medical Officer | N/A | N/A | N/A |
| Ms. Leanne Ralph AAICD, ACIS, BBus | Company Sec. | N/A | N/A | N/A |
| Dr. Walton A. Taylor | Medical Director | N/A | N/A | N/A |
Description
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Corporate governance
ImpediMed Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.
